eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement

NIEL and GHENT, Belgium, July 13, 2021 /PRNewswire/ -- eTheRNA immunotherapies NV ('eTheRNA'), a clinical-stage company developing mRNA immunotherapies for the treatment of cancer and infectious diseases, announces a collaboration and license agreement with Ghent University. Under the...

from PR Newswire: https://ift.tt/36vSQMu